NOVARTIS AG : Morgan Stanley from Sell to Neutral -September 25, 2023 at 04:19 am EDT
Morgan Stanley's analyst Mark Purcell upgrades the rating on the company from Sell to Neutral. The target price has been raised to CHF 98 from CHF 93.
Stay updated with breaking news from Mark Purcell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Morgan Stanley's analyst Mark Purcell upgrades the rating on the company from Sell to Neutral. The target price has been raised to CHF 98 from CHF 93.
Just eight names were trading in positive territory on the FTSE 100 on Monday afternoon as investors scaled back their appetite for risk, with the mining stocks, Entain and Burberry bearing the brunt of the selling pressure.
Ozempic commercials are, at this point, ubiquitous; it represents confirmation that weight loss drugs are big in the pharmaceuticals industry.
THIS is a roundup of this week’s criminal court and inquest stories that we have covered over the last week.
KEVIN EGAN looks at the strengths and weaknesses of the teams that will be competing in this year’s Hodson Bay Hotel Senior Football Championship…